Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $50.00 | 1 | 51.1% |
| Food and Beverage | $25.96 | 2 | 26.5% |
| Education | $21.92 | 2 | 22.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $50.00 | 1 | $0 (2017) |
| Alnylam Pharmaceuticals Inc. | $20.24 | 1 | $0 (2022) |
| Novo Nordisk Inc | $14.92 | 1 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $12.72 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.24 | 1 | Alnylam Pharmaceuticals Inc. ($20.24) |
| 2017 | $77.64 | 4 | Merck Sharp & Dohme Corporation ($50.00) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Education | In-kind items and services | $20.24 | General |
| Category: Genetic Disease | ||||||
| 03/02/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Education | In-kind items and services | $1.68 | General |
| Category: Lower GI | ||||||
| 02/24/2017 | Merck Sharp & Dohme Corporation | IMPLANON (Drug) | — | Cash or cash equivalent | $50.00 | Research |
| Study: Nexplanon Observational Risk Assessment Study NORA • Category: WOMENS HEALTH | ||||||
| 01/18/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Obesity | ||||||
| 01/04/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Central Nervous System (CNS) | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Nexplanon Observational Risk Assessment Study NORA | Merck Sharp & Dohme Corporation | $50.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 443 | 623 | $107,228 | $45,453 |
| 2022 | 5 | 378 | 516 | $90,406 | $34,374 |
| 2021 | 8 | 434 | 600 | $116,234 | $39,836 |
| 2020 | 6 | 417 | 591 | $80,067 | $28,334 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 250 | $31,750 | $15,468 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $45,140 | $15,464 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 180 | $16,334 | $7,455 | 45.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 27 | 27 | $5,184 | $3,469 | 66.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $7,080 | $2,429 | 34.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 29 | 29 | $1,740 | $1,169 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 221 | $32,704 | $13,312 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $30,132 | $10,309 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 176 | $18,128 | $7,543 | 41.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $8,024 | $2,761 | 34.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 21 | $1,418 | $449.18 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 270 | $46,215 | $16,826 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 73 | 73 | $30,441 | $9,475 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 153 | $19,315 | $6,633 | 34.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 25 | 25 | $13,275 | $4,122 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 16 | $3,990 | $1,497 | 37.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 32 | $2,518 | $815.34 | 32.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 12 | 12 | $480.00 | $467.04 | 97.3% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 13 | 19 | $0.19 | $0.19 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 194 | 319 | $28,727 | $9,914 | 34.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 108 | 151 | $19,368 | $7,042 | 36.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 28 | 28 | $13,944 | $4,771 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 38 | 38 | $12,844 | $4,381 | 34.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 18 | $3,078 | $1,246 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 12 | $1,056 | $495.12 | 46.9% |
About Dr. Kristina Corso, DO
Dr. Kristina Corso, DO is a Family Medicine healthcare provider based in Albany, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1275829038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristina Corso, DO has received a total of $97.88 in payments from pharmaceutical and medical device companies, with $20.24 received in 2022. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "" ($50.00).
As a Medicare-enrolled provider, Corso has provided services to 1,672 Medicare beneficiaries, totaling 2,330 services with total Medicare billing of $147,998. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Albany, OR
- Active Since 06/21/2011
- Last Updated 10/29/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275829038
Products in Payments
- IMPLANON (Drug) $50.00
- ONPATTRO (Drug) $20.24
- Saxenda (Drug) $14.92
- Trintellix (Drug) $11.04
- Amitiza (Drug) $1.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Albany
Daniel Arenos, M.d, M.D
Family Medicine — Payments: $26,134
Bruce Houston, D.o, D.O
Family Medicine — Payments: $23,151
Mr. Michael Satchell, Md, MD
Family Medicine — Payments: $20,355
Theodore Hausler, D.o, D.O
Family Medicine — Payments: $16,979
Stephanie Williams, M.d, M.D
Family Medicine — Payments: $16,489
Mr. Derek Heard, Md, MD
Family Medicine — Payments: $15,696